Regulatory effect of miR-142-5p on inflammatory process of sepsis by targeting CXCL8

Ling Wu, Qiqi Shen, Xue‐jie Yu, Youfu Li, Dan FengHereditas 2025 · DOI

Abstract

miR-142-5p may alleviate sepsis by targeting CXCL8-mediated inflammation, suggesting its potential as a diagnostic biomarker and therapeutic target.

Introduction

Sepsis is a life-threatening condition characterized by a dysregulated immune response to infection, often leading to rapid organ failure and high mortality rates. The "cytokine storm"—a hyperactive release of inflammatory markers such as IL-6 and TNF-α—is the primary driver of disease progression. While microRNAs (miRNAs) are known to fine-tune protein expression, the specific regulatory mechanisms controlling this cascade remain under investigation. This study explores the role of miR-142-5p as a critical "molecular brake" that fails during sepsis, leading to an overproduction of inflammatory signals via the target gene CXCL8.

Methods

The researchers employed a multi-level approach combining clinical data with in vitro molecular biology:

  • Clinical Cohort: Serum was analyzed from 110 sepsis patients and 110 healthy controls using qPCR for miRNA levels and ELISA for inflammatory cytokines.
  • Cellular Modeling: Human THP-1 monocytes were used to simulate a sepsis-like state via Lipopolysaccharide (LPS) induction.
  • Functional Assays: Gain-of-function (mimics) and loss-of-function (inhibitors) experiments were conducted to observe the effects on cytokine production.
  • Target Verification: A dual-luciferase reporter assay confirmed the physical binding of miR-142-5p to the 3’-UTR region of the CXCL8 gene.

Key Results

Clinical Downregulation and Diagnostic Potential

Clinical analysis revealed that miR-142-5p levels are significantly lower in sepsis patients compared to healthy individuals. This depletion serves as a high-accuracy indicator of disease presence and severity.

Relative expression of miR-142-5p is significantly lower in sepsis patients compared to healthy controls.

The study found that miR-142-5p demonstrated excellent diagnostic potential with an Area Under the Curve (AUC) of 0.917, showing a sensitivity of 81.8% and a specificity of 87.3%. Furthermore, miR-142-5p levels were strongly negatively correlated with established markers like CRP (r = -0.707) and PCT (r = -0.611).

Correlation with the Cytokine Storm

The loss of miR-142-5p is directly correlated with higher levels of systemic inflammation. Specifically, a strong negative correlation was observed between the miRNA's expression and the levels of TNF-α, a key pro-inflammatory cytokine.

Negative correlation between miR-142-5p expression and TNF-α levels (r = -0.682, p < 0.001).

Direct Targeting of CXCL8

The study confirmed that miR-142-5p actively suppresses inflammation by binding to CXCL8 (IL-8). When miR-142-5p levels are low, CXCL8 expression increases, driving leukocyte trafficking and the subsequent cytokine storm. In "rescue" experiments, overexpressing CXCL8 reversed the anti-inflammatory benefits of miR-142-5p, confirming it as the primary mediator in this pathway.

Discussion and Limitations

miR-142-5p acts as an independent protective factor; for every unit increase in its expression, the risk of sepsis was reduced by approximately 50.2%. While these findings suggest miR-142-5p mimics could be a potential therapy, several challenges remain. The current in vitro work was limited to the THP-1 monocytic line, whereas sepsis involves complex interactions across multiple cell types. Additionally, delivering miRNA mimics effectively to patients in septic shock is a significant bioengineering hurdle. Future research may involve genome-wide CRISPR screening to identify other targets and integrating pan-cancer style signatures to refine sepsis subtype analysis.

Conclusion

miR-142-5p is a potent diagnostic biomarker and a potential therapeutic target for sepsis. By directly suppressing the pro-inflammatory chemokine CXCL8, this microRNA helps regulate the immune response, offering a new roadmap for managing this life-threatening condition.

Summary updated

Abstract

miR-142-5p may alleviate sepsis by targeting CXCL8-mediated inflammation, suggesting its potential as a diagnostic biomarker and therapeutic target.
BibTeX
@inproceedings{wu2025regulatory,
  author = {Ling Wu and Qiqi Shen and Xue‐jie Yu and Youfu Li and Dan Feng},
  title = {{Regulatory effect of miR-142-5p on inflammatory process of sepsis by targeting CXCL8}},
  booktitle = {Hereditas},
  year = {2025},
  doi = {10.1186/s41065-025-00567-5},
}
Figure